About Solute carrier family 7 member 13
Solute carrier family 7 member 13 (SLC7A13) is a protein
from Homo sapiens identified by UniProt accession
Q8TCU3, 470 residues long.
MolForge cross-references it against 0 known binders and
29 disease associations.
Target properties
| Protein name | Solute carrier family 7 member 13 |
| UniProt accession | Q8TCU3 |
| Gene | SLC7A13 |
| Organism | Homo sapiens |
| Length | 470 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (29)
Diseases linked to this target (Open Targets).
- creatinine measurement · score 0.32
- self reported educational attainment · score 0.29
- cystatin C measurement · score 0.29
- low density lipoprotein cholesterol measurement · score 0.28
- mathematical ability · score 0.27
- glomerular filtration rate · score 0.26
- urate measurement · score 0.25
- total cholesterol measurement · score 0.20
- cognitive function measurement · score 0.20
- neutrophil count · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8TCU3-F1 | alphafold | PREDICTED | 88.19 | — |
Amino-acid sequence (470 residues)
MDRGEKIQLK RVFGYWWGTS FLLINIIGAG IFVSPKGVLA YSCMNVGVSL CVWAGCAILA MTSTLCSAEI SISFPCSGAQ YYFLKRYFGS TVAFLNLWTS LFLGSGVVAG QALLLAEYSI QPFFPSCSVP KLPKKCLALA MLWIVGILTS RGVKEVTWLQ IASSVLKVSI LSFISLTGVV FLIRGKKENV ERFQNAFDAE LPDISHLIQA IFQGYFAYSG GACFTLIAGE LKKPRTTIPK CIFTALPLVT VVYLLVNISY LTVLTPREIL SSDAVAITWA DRAFPSLAWI MPFAISTSLF SNLLISIFKS SRPIYLASQE GQLPLLFNTL NSHSSPFTAV LLLVTLGSLA IILTSLIDLI NYIFFTGSLW SILLMIGILR RRYQEPNLSI PYKVFLSFPL ATIVIDVGLV VIPLVKSPNV HYVYVLLLVL SGLLFYIPLI HFKIRLAWFE KMTCYLQLLF NICLPDVSEE
Explore Solute carrier family 7 member 13 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets